Page 119 - Clinical variability in Noonan syndrome with emphasison ear and eye

References
1. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nature Genetics. 2001;29:465-468.
2. Van der Burgt I. Noonan syndrome. Orphanet Journal of Rare Diseases. 2007;2:4.
3. Lepri FR, Scavelli R, Digilio MC, Gnazzo M, Grotta S, Dentici ML, et al. Diagnosing of Noonan syndrome ad related disorders using target next generation sequencing. B M C
Med Genet. 2014;15:14.
4. Zenker M, Buheitel G, Rauch R, Koenig R, Bosse K, Kress W, et al. Genotype-phenotype
correlations in Noonan syndrome. J Pediatr. 2004;144:368-374.
5. Jongmans M, Sistermans EA, Rikken A, Nillesen WM, Tamminga R, Patton M, et al. Genotypic
and phenotypic characterization of Noonan syndrome: new data and review of the literature.
Am J Med Genet A. 2005;134A:165-170.
6. Allanson JE, Bohring A, Dorr HG, Dufke A, Gillessen-Kaesbach G, Horn D, et al. The face of
Noonan syndrome: does phenotype predict genotype. Am J Med Genet A. 2010;152A:1960-
1966.
7. Carta C, Pantaleoni F, Bocchinfuso G, Stella L, Vasta I, Sarkozy A, et al. Germline missense
mutations affecting KRAS isoform B are associated with a severe Noonan syndrome
phenotype. American Journal of Human Genetics. 2006;79:129-135.
8. Narumi Y, Aoki Y, Niihori T, Sakurai M, Cavé H, Verloes A, et al. Clinical manifestations in patients with SOS1 mutations range from Noonan syndrome to CFC syndrome. J Hum
Genet. 2008;53:834-841.
9. Allanson JE, Hall JG, Hughes HE, Preus M, Witt RD. Noonan syndrome: the changing
phenotype. American Journal of Medical Genetics. 1985;21(3):507-14.
10. Moncini S, Bonati MT, Morella I, Ferrari L, Brambilla R, Riva P. Differential allelic expression of SOS1 and hyperexpression of the activating SOS1 c.755C variant in a Noonan syndrome
family. Eur J Hum Genet. 2015;23:1531-1537.
11. Serre D, Gurd S, Ge B, Sladek R, Sinnett D, Harmsen E, et al. Differential allelic expression
in the human genome: a robust approach to identify genetic and epigenetic cis-acting
mechanisms regulating gene expression. PLoS Genet. 2008;4:e100006.
12. Mendez HM, Opitz JM. Noonan syndrome: a review. American Journal of Medical Genetics.
1985;21:493-506.
13. Lee NB, Kelly L, Sharland M. Ocular manifestations of Noonan syndrome. Eye. 1992;6:328-
334.
14. Group: TNSGD, Kerr B, Van der Burgt I, Biswas S, Clayton-Smith J, Dahlgren J, Gelb, B, et al.
Noonan Syndrome Clinical Management Guidelines. University of Manchester: Dyscerne;
2010.
15. Cremers C. Letter: Hearing loss in Noonan syndrome. Journal of Pediatrics. 1976;88:363.
16. Sharland M, Burch M, McKenna WM, Paton MA. A clinical study of Noonan syndrome.
Archives of Disease in Childhood. 1992;67:178-183.
17. Qiu WW, Yin SS, Stucker FJ. Audiologic manifestations of Noonan syndrome. Otolaryngology
Head and Neck Surgery. 1998;118:319-323.
18. Scheiber C, Hirschfelder A, Grabel S, peters H, Olze H. Bilateral cochlear implantation in
children with Noonan syndrome. Int J Pediatr Otorhinolaryngol. 2009;73:889-894.
19. Chu HS, Chung HS, Ko MH, Kim HJ, Ki CS, Chung WH, et al. Syndromic hearing loss in association with PTPN11-related disorder: the experience of cochlear implantation in a
child with LEOPARD syndrome. Clin Exp Otorhinolaryngol. 2013;6:99-102.
NEDERLANDSE SAMENVATTING
117
8